Here we talk to you through some of the factors that have sparked the increase in the use and challenges of Decentralised clinical trials. Especially with the start of the COVID-19 pandemic, companies were faced with the challenge to keep the patients in their ongoing clinical trials. Regulatory authorities also had to adjust quickly to support the new approaches to clinical trials.

This is a short clip from our ‘Webinar: Patients First! Decentralization – The (new) Clinical Trial Paradigm’ webinar.

Date: Live webinar: 27 January 2022

Category: Decentralised Clinical Trials